Summary

Dr. Roger Stanzel discusses how point-of-care testing with the
i-STAT System led to improvements in ACT result availability and quality at Queen Elizabeth II Healthcare Sciences Center in Halifax, Nova Scotia.

Content about the webinar:

Fast and accurate measurement of activated clotting time (ACT) is essential during cardiopulmonary bypass (CPB) surgery to monitor the degree of heparin-induced anti-coagulation. Delayed or inaccurate ACT results can put patients at risk for thrombosis and haemorrhage.

Key Topics:

• How delayed or inaccurate ACT results during CPB surgery can impact patient safety.
• Testing factors that can affect result accuracy, including user error, reproducibility, and device QA.
• How intraoperative, point-of-care blood testing enables clinical team members to stay in the OR and deliver care in a safer and more timely manner.
• The operational and clinical advantages of using a versatile, portable analyser that performs multiple tests.

About Presenter

Dr. Roger Stanzel is the Clinical Perfusion Lead and Perfusion Research Director for the Nova Scotia Health Authority in Halifax, Nova Scotia, Canada. 

He is an Adjunct Professor in the departments of Surgery and Graduate Studies at Dalhousie University in Halifax and has published and lectured widely on topics related to perfusion and thrombosis in cardiac surgery. Dr. Stanzel holds a PhD from the Department of Biology at Queen’s University in Ontario, Canada.